Pestalozzi advises Covance Inc. on the USD 15 million purchase of Swiss Pharma Contract
Covance expanded its clinical pharmacology presence in Europe with the acquisition of Swiss Pharma Contract, a contract research organization (CRO) in Basel, Switzerland. Swiss Pharma Contract provides clinical research services to the pharmaceutical, biotechnology, and medicaldevice industries. The Swiss Pharma facility is Covance’s first foray into clinical pharmacology in Switzerland. Pestalozzi acted as counsel to Covance.